MONDAY, March 4, 2019 -- For years, doctors have debated the safety of the acne drug most commonly known as Accutane, but new research suggests the medication does not boost depression risk among its users.
"The existing literature to date is quite mixed with regards to the issue of whether there is or is not an association between isotretinoin [Accutane] use and increased risk of depression," explained study author Dr. Bethanee Schlosser.
TUESDAY, Feb. 26, 2019 -- For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study.
Keytruda (pembrolizumab) is a PD-1 inhibitor, an immunotherapy drug that triggers the body's immune response to attack cancer cells. According to results of this study, the drug's effects peak as early as seven days after treatment -- much earlier than previously seen in other studies.
TUESDAY, Feb. 12, 2019 -- Are your feet something you think about only when they hurt? Simple steps can protect them from common problems, some of which are hard to get rid of.
The first step is to wear shoes, such as water slip-ons, in moist environments like indoor swimming pools and communal showers at the gym. Damp areas allow bacteria and viruses to thrive, and walking barefoot makes you more susceptible to common infections like nail fungus, athlete's foot and warts.
THURSDAY, Jan. 17, 2019 -- About half of the population will one day have a vein problem.
For some, it will involve the thinner, blotchy spider veins that don't bother some people, but cause itching or burning in others. Still others will be plagued by the more noticeable bulging of varicose veins.